Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Cash & Equivalents	0.02	0.16	0.03	0.03	0.07
Cash & Short-Term Investments	0.02	0.16	0.03	0.03	0.07
Cash Growth	-87.14%	483.82%	-19.90%	-50.98%	1925.42%
Accounts Receivable	0.14	0.03	0.06	0.07	0.08
Other Receivables	0.16	0.19	0.09	0.11	0.17
Receivables	0.3	0.22	0.15	0.18	0.26
Inventory	0.26	0.17	0.16	0.28	0.37
Prepaid Expenses	0.06	0.1	0.06	0.09	0.1
Other Current Assets	0.03	0.03	0.03	0.03	-
Total Current Assets	0.66	0.68	0.42	0.61	0.8
Property, Plant & Equipment	0.97	1.21	1.83	2.45	3.03
Total Assets	1.63	1.89	2.25	3.07	3.83
Accounts Payable	1.94	1.12	2.78	1.36	1.83
Accrued Expenses	2.29	1.47	-	-	-
Short-Term Debt	2.61	0.21	1.57	0.76	1.23
Current Portion of Long-Term Debt	-	0.09	0.19	-	-
Current Portion of Leases	-	0.03	0.34	0.31	0.29
Current Unearned Revenue	-	-	0.01	0.02	0.9
Total Current Liabilities	6.84	2.92	4.89	2.45	4.25
Long-Term Debt	-	2.12	-	-	-
Long-Term Leases	-	-	0.03	0.36	0.67
Total Liabilities	6.84	5.04	4.92	2.82	4.92
Common Stock	28.26	26.61	25.13	25	18.6
Additional Paid-In Capital	6.65	5.24	4.85	4.15	2.64
Retained Earnings	-44.6	-39.26	-34.97	-31.16	-22.67
Comprehensive Income & Other	4.49	4.24	2.32	2.26	0.34
Shareholders' Equity	-5.21	-3.16	-2.67	0.25	-1.09
Total Liabilities & Equity	1.63	1.89	2.25	3.07	3.83
Total Debt	2.61	2.45	2.12	1.43	2.19
Net Cash (Debt)	-2.59	-2.29	-2.1	-1.4	-2.12
Net Cash Per Share	-0.02	-0.02	-0.02	-0.01	-0.03
Filing Date Shares Outstanding	129.53	122.3	103.57	103.07	80.67
Total Common Shares Outstanding	129.53	117.81	103.57	103.07	80.67
Working Capital	-6.18	-2.24	-4.47	-1.84	-3.45
Book Value Per Share	-0.04	-0.03	-0.03	0.00	-0.01
Tangible Book Value	-5.21	-3.16	-2.67	0.25	-1.09
Tangible Book Value Per Share	-0.04	-0.03	-0.03	0.00	-0.01
Machinery	2.4	2.39	2.39	2.39	2.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.